PL369297A1 - Organoleptycznie dopuszczalne rozpuszczalne w ustach kompozycje - Google Patents
Organoleptycznie dopuszczalne rozpuszczalne w ustach kompozycjeInfo
- Publication number
- PL369297A1 PL369297A1 PL02369297A PL36929702A PL369297A1 PL 369297 A1 PL369297 A1 PL 369297A1 PL 02369297 A PL02369297 A PL 02369297A PL 36929702 A PL36929702 A PL 36929702A PL 369297 A1 PL369297 A1 PL 369297A1
- Authority
- PL
- Poland
- Prior art keywords
- organoleptically acceptable
- disintegrating compositions
- intraorally disintegrating
- intraorally
- compositions
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
- A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Rheumatology (AREA)
- Physiology (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Pain & Pain Management (AREA)
- Zoology (AREA)
- Nutrition Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Inorganic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US32535601P | 2001-09-26 | 2001-09-26 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL369297A1 true PL369297A1 (pl) | 2005-04-18 |
Family
ID=23267542
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL02369297A PL369297A1 (pl) | 2001-09-26 | 2002-09-23 | Organoleptycznie dopuszczalne rozpuszczalne w ustach kompozycje |
| PL02369298A PL369298A1 (pl) | 2001-09-26 | 2002-09-23 | Rozpuszczalne w ustach kompozycje waldekoksibu |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL02369298A PL369298A1 (pl) | 2001-09-26 | 2002-09-23 | Rozpuszczalne w ustach kompozycje waldekoksibu |
Country Status (25)
| Country | Link |
|---|---|
| US (1) | US20030181501A1 (pl) |
| EP (2) | EP1490035A1 (pl) |
| JP (2) | JP2005512964A (pl) |
| KR (2) | KR20040058189A (pl) |
| CN (2) | CN1633281A (pl) |
| AP (2) | AP2004002999A0 (pl) |
| AR (1) | AR037239A1 (pl) |
| BR (2) | BR0212861A (pl) |
| CA (2) | CA2461630A1 (pl) |
| CO (2) | CO5570684A2 (pl) |
| EA (2) | EA200400357A1 (pl) |
| EC (1) | ECSP045029A (pl) |
| GE (1) | GEP20063856B (pl) |
| HK (1) | HK1079988A1 (pl) |
| IL (2) | IL160855A0 (pl) |
| IS (2) | IS7177A (pl) |
| MA (2) | MA27682A1 (pl) |
| MX (2) | MXPA04002798A (pl) |
| NO (2) | NO20041258L (pl) |
| OA (2) | OA12707A (pl) |
| PL (2) | PL369297A1 (pl) |
| TN (2) | TNSN04045A1 (pl) |
| WO (2) | WO2003026697A2 (pl) |
| YU (1) | YU34804A (pl) |
| ZA (2) | ZA200401953B (pl) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2005002557A1 (en) * | 2003-07-03 | 2005-01-13 | Warner-Lambert Company Llc | Pharmaceutical compositions including an ether and selective cox-2 inhibitor and uses thereof |
| US20050186271A1 (en) * | 2004-02-24 | 2005-08-25 | Sheskey Paul J. | Process for dispersing a fluid in a mass of solid particles |
| KR20130018956A (ko) * | 2004-08-10 | 2013-02-25 | 아지노모토 가부시키가이샤 | 쓴맛이 감소된 나테글리니드 함유 제제 |
| EP1839650A1 (en) * | 2004-12-28 | 2007-10-03 | Eisai R&D Management Co., Ltd. | Quick disintegration tablet and method of producing the same |
| US8497258B2 (en) | 2005-11-12 | 2013-07-30 | The Regents Of The University Of California | Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract |
| CN101340899A (zh) * | 2005-12-20 | 2009-01-07 | 卫材R&D管理有限公司 | 含有脂溶性药物的口腔内速崩片 |
| US8535714B2 (en) | 2006-01-06 | 2013-09-17 | Acelrx Pharmaceuticals, Inc. | Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain |
| US8202535B2 (en) * | 2006-01-06 | 2012-06-19 | Acelrx Pharmaceuticals, Inc. | Small-volume oral transmucosal dosage forms |
| US8252329B2 (en) | 2007-01-05 | 2012-08-28 | Acelrx Pharmaceuticals, Inc. | Bioadhesive drug formulations for oral transmucosal delivery |
| US8865743B2 (en) | 2006-01-06 | 2014-10-21 | Acelrx Pharmaceuticals, Inc. | Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain |
| US20090136570A1 (en) * | 2006-01-20 | 2009-05-28 | Bhagwant Rege | Taste-Masked Tablets and Granules |
| US20070196494A1 (en) * | 2006-02-17 | 2007-08-23 | Arnaud Grenier | Low-friability, patient-friendly orally disintegrating formulations |
| EP2026792A2 (en) * | 2006-05-19 | 2009-02-25 | Somaxon Pharmaceuticals, Inc. | Low dose doxepin formulations, including buccal, sublingual and fastmelt formulations, and uses of the same to treat insomnia |
| CN101686931B (zh) * | 2007-06-06 | 2013-06-19 | 巴斯夫欧洲公司 | 用于制备可咀嚼片剂和锭剂的药物配制剂 |
| WO2008148731A1 (de) * | 2007-06-06 | 2008-12-11 | Basf Se | Pharmazeutische formulierung für die herstellung von schnell zerfallenden tabletten |
| CN102046147B (zh) * | 2007-06-06 | 2013-03-20 | 巴斯夫欧洲公司 | 用于制备快速崩解的片剂的药物配制剂 |
| CN101707930B (zh) * | 2007-06-06 | 2013-10-30 | 巴斯夫欧洲公司 | 用于制备快速崩解的片剂的药物配制剂 |
| JP5632284B2 (ja) * | 2007-08-07 | 2014-11-26 | エーセルアールエックス ファーマシューティカルズ， インコーポレイテッド | 経口経粘膜剤形を使用する処置時の鎮静および無痛のための組成物および方法 |
| US20110086070A1 (en) * | 2008-03-24 | 2011-04-14 | Munish Talwar | Orally disintegrating compositions of rhein or diacerein |
| US8945592B2 (en) * | 2008-11-21 | 2015-02-03 | Acelrx Pharmaceuticals, Inc. | Sufentanil solid dosage forms comprising oxygen scavengers and methods of using the same |
| CN102988318A (zh) * | 2008-11-25 | 2013-03-27 | 田边三菱制药株式会社 | 口腔速崩片及其制备方法 |
| EP2440210A4 (en) | 2009-06-12 | 2014-01-29 | Meritage Pharma Inc | METHOD FOR THE TREATMENT OF STOMACH DARM DISEASES |
| US20110091544A1 (en) * | 2009-10-16 | 2011-04-21 | Acelrx Pharmaceuticals, Inc. | Compositions and Methods for Mild Sedation, Anxiolysis and Analgesia in the Procedural Setting |
| FR2968995B1 (fr) * | 2010-12-16 | 2013-03-22 | Sanofi Aventis | Composition pharmaceutioue pour une administration par voie orale destinee a eviter le mesusage |
| CN106822007B (zh) | 2015-09-11 | 2021-12-31 | 西姆莱斯股份公司 | 口服制剂 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5474995A (en) * | 1993-06-24 | 1995-12-12 | Merck Frosst Canada, Inc. | Phenyl heterocycles as cox-2 inhibitors |
| US5576014A (en) * | 1994-01-31 | 1996-11-19 | Yamanouchi Pharmaceutical Co., Ltd | Intrabuccally dissolving compressed moldings and production process thereof |
| US5633272A (en) * | 1995-02-13 | 1997-05-27 | Talley; John J. | Substituted isoxazoles for the treatment of inflammation |
| ZA964928B (en) * | 1995-06-13 | 1997-12-10 | American Home Prod | Oral formulations of S(+)-etodolac. |
| PT855988E (pt) * | 1995-10-20 | 2002-10-31 | Upjohn Co | Embalagem de bolhas |
| JPH11512754A (ja) * | 1996-05-17 | 1999-11-02 | メルク エンド カンパニー インコーポレーテッド | シクロオキシゲナーゼ―２媒介疾患の一日一回治療用組成物 |
| EP0863134A1 (en) * | 1997-03-07 | 1998-09-09 | Merck Frosst Canada Inc. | 2-(3,5-difluorophenyl)-3-(4-(methyl-sulfonyl)phenyl)-2-cyclopenten-1-one useful as an inhibitor of cyclooxygenase-2 |
| US6465009B1 (en) * | 1998-03-18 | 2002-10-15 | Yamanouchi Pharmaceutical Co., Ltd. | Water soluble polymer-based rapidly dissolving tablets and production processes thereof |
| CN1679556A (zh) * | 1999-12-08 | 2005-10-12 | 法马西亚公司 | 维得克西组合物 |
| US6316029B1 (en) * | 2000-05-18 | 2001-11-13 | Flak Pharma International, Ltd. | Rapidly disintegrating solid oral dosage form |
| US6800297B2 (en) * | 2000-06-15 | 2004-10-05 | Acusphere, Inc. | Porous COX-2 inhibitor matrices and methods of manufacture thereof |
| EP1309315B1 (en) * | 2000-08-18 | 2006-06-14 | Pharmacia Corporation | Rapidly disintegrating oral formulation of valdecoxib |
| CN1638739A (zh) * | 2000-08-18 | 2005-07-13 | 法玛西雅厄普约翰美国公司 | 治疗成瘾性障碍的化合物 |
-
2002
- 2002-09-23 AP APAP/P/2004/002999A patent/AP2004002999A0/en unknown
- 2002-09-23 PL PL02369297A patent/PL369297A1/pl not_active Application Discontinuation
- 2002-09-23 EA EA200400357A patent/EA200400357A1/ru unknown
- 2002-09-23 US US10/252,222 patent/US20030181501A1/en not_active Abandoned
- 2002-09-23 KR KR10-2004-7004334A patent/KR20040058189A/ko not_active Application Discontinuation
- 2002-09-23 EP EP02775948A patent/EP1490035A1/en not_active Withdrawn
- 2002-09-23 JP JP2003530260A patent/JP2005512964A/ja not_active Withdrawn
- 2002-09-23 JP JP2003530331A patent/JP2005506987A/ja not_active Withdrawn
- 2002-09-23 BR BR0212861-6A patent/BR0212861A/pt not_active IP Right Cessation
- 2002-09-23 WO PCT/US2002/030048 patent/WO2003026697A2/en active Application Filing
- 2002-09-23 AP APAP/P/2004/002998A patent/AP2004002998A0/en unknown
- 2002-09-23 YU YU34804A patent/YU34804A/sh unknown
- 2002-09-23 EP EP02773522A patent/EP1429736A2/en not_active Withdrawn
- 2002-09-23 CA CA002461630A patent/CA2461630A1/en not_active Abandoned
- 2002-09-23 KR KR10-2004-7004373A patent/KR20040044990A/ko not_active Application Discontinuation
- 2002-09-23 BR BR0212778-4A patent/BR0212778A/pt not_active IP Right Cessation
- 2002-09-23 OA OA1200400083A patent/OA12707A/en unknown
- 2002-09-23 PL PL02369298A patent/PL369298A1/pl not_active Application Discontinuation
- 2002-09-23 GE GE5525A patent/GEP20063856B/en unknown
- 2002-09-23 CN CNA028211413A patent/CN1633281A/zh active Pending
- 2002-09-23 IL IL16085502A patent/IL160855A0/xx unknown
- 2002-09-23 MX MXPA04002798A patent/MXPA04002798A/es unknown
- 2002-09-23 OA OA1200400082A patent/OA13060A/en unknown
- 2002-09-23 EA EA200400352A patent/EA200400352A1/ru unknown
- 2002-09-23 WO PCT/US2002/030161 patent/WO2003026623A1/en active Application Filing
- 2002-09-23 CA CA002461044A patent/CA2461044A1/en not_active Abandoned
- 2002-09-23 MX MXPA04002652A patent/MXPA04002652A/es unknown
- 2002-09-23 CN CNA028189078A patent/CN1703203A/zh active Pending
- 2002-09-23 IL IL16084802A patent/IL160848A0/xx unknown
- 2002-09-26 AR ARP020103627A patent/AR037239A1/es unknown
-
2004
- 2004-03-10 ZA ZA200401953A patent/ZA200401953B/en unknown
- 2004-03-11 IS IS7177A patent/IS7177A/is unknown
- 2004-03-11 IS IS7178A patent/IS7178A/is unknown
- 2004-03-23 EC EC2004005029A patent/ECSP045029A/es unknown
- 2004-03-23 TN TNP2004000045A patent/TNSN04045A1/fr unknown
- 2004-03-24 MA MA27586A patent/MA27682A1/fr unknown
- 2004-03-24 TN TNP2004000047A patent/TNSN04047A1/fr unknown
- 2004-03-24 MA MA27587A patent/MA27542A1/fr unknown
- 2004-03-25 ZA ZA200402364A patent/ZA200402364B/xx unknown
- 2004-03-25 NO NO20041258A patent/NO20041258L/no not_active Application Discontinuation
- 2004-03-26 CO CO04028409A patent/CO5570684A2/es not_active Application Discontinuation
- 2004-03-26 CO CO04028410A patent/CO5570659A2/es not_active Application Discontinuation
- 2004-04-15 NO NO20041532A patent/NO20041532L/no not_active Application Discontinuation
-
2006
- 2006-01-04 HK HK06100055.6A patent/HK1079988A1/zh unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1079988A1 (zh) | 感官可接受的口腔內崩解組合物 | |
| HUP0600342A2 (en) | Glycoprotein compositions | |
| GB0407745D0 (en) | Sunscreen compositions | |
| PL365518A1 (pl) | Kompozycja doustna | |
| HUP0400174A2 (en) | Lipid-polymer-conjugates compositions | |
| GB0126244D0 (en) | Oral compositions | |
| GB0200763D0 (en) | Compositions | |
| AU2002365093A8 (en) | Therapeutic compositions | |
| GB0105622D0 (en) | Compositions | |
| GB0016067D0 (en) | Oral compositions | |
| GB0009609D0 (en) | Therapeutic compositions | |
| GB0030857D0 (en) | Therapeutic compositions | |
| GB0000438D0 (en) | Dental compositions | |
| GB0022297D0 (en) | Oral compositions | |
| GB0109428D0 (en) | Therapeutic compositions | |
| GB0018230D0 (en) | Dental compositions | |
| GB0103328D0 (en) | Compositions | |
| GB0115893D0 (en) | Formulations | |
| GB0108815D0 (en) | Dental compositions | |
| GB0125699D0 (en) | Dental chisel | |
| GB0008282D0 (en) | Dental compositions | |
| GB0018227D0 (en) | Dental compositions | |
| EG23003A (en) | Synergistic formulations | |
| GB2390303B (en) | Oral compositions | |
| AU2002366052A8 (en) | Dentifrice compositions |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| REFS | Decisions on refusal to grant patents (taken after the publication of the particulars of the applications) |